EUVIMEDEUVIMED entdecken
Multizentrische Studie

A Multicenter Retrospective Study on Screening Patients Eligible for Exemption From Axillary Surgery Based on the Pathological Remission of the Breast After Neoadjuvant Therapy

Xingye Sheng, Hong Yin, Xiaoqing Zhang, Lingjun Ma, Xinyu Wan, Wenxiang Shi, Mingyu Wang, Junhan Li, Danni Shen, Ying Zhu, Weifeng Qian, Jue Wang

Clinical Breast Cancer · 2026

DOI: 10.1016/j.clbc.2026.08.002 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Breast Cancer, 2026. Verfasst von Xingye Sheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Breast Neoplasms, Lymph Node Excision. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Chinese Society of Clinical Oncology, Wu Jieping Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyBreast NeoplasmsLymph Node ExcisionHumansFemaleRetrospective StudiesMiddle AgedPathologic Complete ResponseAxillaAdultAgedErb-b2 Receptor Tyrosine KinasesLymphatic MetastasisLymph NodesNeoplasm Staging

Stichwörter der Autor:innen

Axillary surgery omissionBreast cancerBreast pathologic complete responseClinical nodal stageNeoadjuvant systemic therapy

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Department of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Breast Surgery, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), Nanjing, China.
  • Department of Breast Disease, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
  • Department of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Gastrointestinal Surgery, Changzhou Medical Center, Affiliated Changzhou No.2 People's Hospital of…
  • Department of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Department of Breast and Thyroid Surgery, Gusu School, The Affiliated Suzhou Hospital of Nanjing Medical Univers…
  • Department of General Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China. Electronic address: zhuying_nanjing@126.com.

Förderung

  • Chinese Society of Clinical Oncology
  • Wu Jieping Medical Foundation

Zitieren

APA

Sheng, X., Yin, H., Zhang, X., Ma, L., Wan, X., Shi, W., Wang, M., Li, J., Shen, D., Zhu, Y., Qian, W., & Wang, J. (2026). A Multicenter Retrospective Study on Screening Patients Eligible for Exemption From Axillary Surgery Based on the Pathological Remission of the Breast After Neoadjuvant Therapy. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.08.002

Vancouver

Sheng X, Yin H, Zhang X, Ma L, Wan X, Shi W, et al. A Multicenter Retrospective Study on Screening Patients Eligible for Exemption From Axillary Surgery Based on the Pathological Remission of the Breast After Neoadjuvant Therapy. Clinical Breast Cancer. 2026. doi:10.1016/j.clbc.2026.08.002

BibTeX
@article{Sheng2026,
  author = {Sheng, Xingye and Yin, Hong and Zhang, Xiaoqing and Ma, Lingjun and Wan, Xinyu and Shi, Wenxiang and Wang, Mingyu and Li, Junhan and Shen, Danni and Zhu, Ying and Qian, Weifeng and Wang, Jue},
  title = {A Multicenter Retrospective Study on Screening Patients Eligible for Exemption From Axillary Surgery Based on the Pathological Remission of the Breast After Neoadjuvant Therapy},
  journal = {Clinical Breast Cancer},
  year = {2026},
  doi = {10.1016/j.clbc.2026.08.002}
}
Kostenlos starten →